PHVS Stock, Pharvaris N.V. Information
Stock Information
Get PHVS Alerts
News, Short Squeeze, Breakout and More Instantly...
About Pharvaris N.V.
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.